학술논문

Artemis: A Multicenter, Open-Label, Single-Arm, Phase II Study to Evaluate the Efficacy and Safety of First-Line Carbo-platin/Paclitaxel/Lenvatinib/Pembrolizumab Combination for Previously Untreated Advanced or Recurrent Thymic Carcinomas
Document Type
Journal
Source
CLINICAL LUNG CANCER; JUN 2024, 25 4, p389-p394, 6p.
Subject
Language
English
ISSN
19380690